Mobeus provided £1m in growth capital to back the electric vehicle charge point manufacturer.
"We have a very clear philosophy, which meant finding the right investment partner, who really understood what drives us, was crucial. Going electric is a choice to embrace a sustainable future and we see EV chargers being at the centre of everyone’s smart energy home. This additional funding means that we are very excited about the next stage in our growth journey."
West Hill Capital led the oversubscribed follow-on investment to fund team growth and product expansion.
"One of our key goals is to eliminate all forms of rental deposits including £4.5bn of cash tied up in rental deposits and deposit alternative products by December 2021."
The oversubscribed round was led by Cambridge Enterprise and will fund the company's transition into drug development.
"We are pleased to welcome on board our new investors and appreciate their confidence in our business. Our aim is to replicate the specificity of biologics in the powerful and scalable form of a small molecule, to treat devastating diseases where there are currently no treatment options. We have proven the strength of our platform in tapping unexplored parts of the chemical universe to find novel and specific hits for currently undruggable targets, and are excited to now be able to invest in our own pipeline of drug discovery programmes, as well as to develop further strategic partnerships."
The seed round was led by Global Founders Capital and Partech with backing from existing investors.
"We are excited to find partners who will accompany us on this journey to build new, employer-based trust layers for financial markets and have raised €5.6m from them"